Guo Q, Qin H, Chen Z, Zhang W, Zheng L, Qin T
Genes Dis. 2025; 12(3):101311.
PMID: 40034124
PMC: 11875185.
DOI: 10.1016/j.gendis.2024.101311.
Nath P, Isakov N
Life (Basel). 2025; 14(12.
PMID: 39768300
PMC: 11677474.
DOI: 10.3390/life14121592.
Peng Z, Zhang H, Hu H
Adv Exp Med Biol. 2024; 1466:135-159.
PMID: 39546141
DOI: 10.1007/978-981-97-7288-9_10.
Jin L
Adv Exp Med Biol. 2024; 1466:113-122.
PMID: 39546139
DOI: 10.1007/978-981-97-7288-9_8.
Jie Z
Adv Exp Med Biol. 2024; 1466:101-111.
PMID: 39546138
DOI: 10.1007/978-981-97-7288-9_7.
Profiling Cullin4-E3 Ligases Interactomes and Their Rewiring in Influenza A Virus Infection.
Dugied G, Douche T, Dos Santos M, Giai Gianetto Q Q, Cassonnet C, Vuillier F
Mol Cell Proteomics. 2024; 23(11):100856.
PMID: 39383947
PMC: 11609542.
DOI: 10.1016/j.mcpro.2024.100856.
Genomic variants associated with age at diagnosis of childhood-onset type 1 diabetes.
Bougneres P, Le Fur S, Kamatani Y, Mai T, Belot M, Perge K
J Hum Genet. 2024; 69(11):585-590.
PMID: 38982180
DOI: 10.1038/s10038-024-01272-3.
Otud6b induces pulmonary arterial hypertension by mediating the Calpain-1/HIF-1α signaling pathway.
Liu Y, Tang B, Wang H, Lu M
Cell Mol Life Sci. 2024; 81(1):258.
PMID: 38878112
PMC: 11335297.
DOI: 10.1007/s00018-024-05291-3.
USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells.
Gao B, Qiao Y, Zhu S, Yang N, Zou S, Liu Y
J Biol Chem. 2024; 300(7):107463.
PMID: 38876304
PMC: 11268115.
DOI: 10.1016/j.jbc.2024.107463.
USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy.
Wu Q, Wang Z, Chen S, She X, Zhu S, Li P
Oncogene. 2024; 43(21):1581-1593.
PMID: 38565942
DOI: 10.1038/s41388-024-03009-0.
Mechanism study of ubiquitination in T cell development and autoimmune disease.
Yu H, Yang W, Cao M, Lei Q, Yuan R, Xu H
Front Immunol. 2024; 15:1359933.
PMID: 38562929
PMC: 10982411.
DOI: 10.3389/fimmu.2024.1359933.
The deubiquitinase Otud7b suppresses cone photoreceptor degeneration in mouse models of retinal degenerative diseases.
Varner L, Chaya T, Maeda Y, Tsutsumi R, Zhou S, Tsujii T
iScience. 2024; 27(4):109380.
PMID: 38510130
PMC: 10951987.
DOI: 10.1016/j.isci.2024.109380.
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application.
Gao H, Yin J, Ji C, Yu X, Xue J, Guan X
J Exp Clin Cancer Res. 2023; 42(1):225.
PMID: 37658402
PMC: 10472646.
DOI: 10.1186/s13046-023-02805-y.
USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression.
Tyagi A, Karapurkar J, Colaco J, Sarodaya N, Antao A, Kaushal K
Mol Biotechnol. 2023; 66(8):2032-2045.
PMID: 37572221
DOI: 10.1007/s12033-023-00814-y.
Mechanism and Modulation of SidE Family Proteins in the Pathogenesis of .
Xie Y, Zhang Y, Wang Y, Feng Y
Pathogens. 2023; 12(4).
PMID: 37111515
PMC: 10143409.
DOI: 10.3390/pathogens12040629.
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21.
Goricke F, Vu V, Smith L, Scheib U, Bohm R, Akkilic N
J Med Chem. 2023; 66(5):3431-3447.
PMID: 36802665
PMC: 10009755.
DOI: 10.1021/acs.jmedchem.2c01933.
USP1-regulated reciprocal differentiation of Th17 cells and Treg cells by deubiquitinating and stabilizing TAZ.
Zhu X, Wang P, Zhan X, Zhang Y, Sheng J, He S
Cell Mol Immunol. 2023; 20(3):252-263.
PMID: 36600049
PMC: 9970968.
DOI: 10.1038/s41423-022-00969-9.
USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective.
Korenev G, Yakukhnov S, Druk A, Golovina A, Chasov V, Mirgayazova R
Cancers (Basel). 2022; 14(22).
PMID: 36428632
PMC: 9688046.
DOI: 10.3390/cancers14225539.
USP7 substrates identified by proteomics analysis reveal the specificity of USP7.
Nie L, Wang C, Liu X, Teng H, Li S, Huang M
Genes Dev. 2022; 36(17-18):1016-1030.
PMID: 36302555
PMC: 9732911.
DOI: 10.1101/gad.349848.122.
The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.
Ju E, Park K, Shen H, Hur G
Exp Mol Med. 2022; 54(9):1401-1411.
PMID: 36171264
PMC: 9534832.
DOI: 10.1038/s12276-022-00847-4.